- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Novel Metabolic Pathways of Vitamin D3-Identification of C-3 Epimerization and C-25 Dehydration Pathways and Biological Activity of Novel Metabolites
-
- Kamao Maya
- Department of Hygienic Sciences, Kobe Pharmaceutical University
-
- Okano Toshio
- Department of Hygienic Sciences, Kobe Pharmaceutical University
Search this article
Description
The active form of vitamin D3, 1α,25-dihydroxyvitamin D3 [1α,25(OH)2D3], functions to maintain calcium and phosphorus homeostasis and plays an important role in cell proliferation and differentiation. Since the discovery of non-classical functions of 1α,25(OH)2D3, many 1α,25(OH)2D3 analogs have been synthesized to separate calcemic properties from the antiproliferative cell-differentiating properties. 1α,25(OH)2D3 and its precursor, 25-hydroxyvitamin D3 [25(OH)D3], are metabolized via C-24 and C-23/26 oxidation pathways. Recently, a novel A-ring modification metabolic pathway of 1α,25(OH)2D3, the C-3 epimerization pathway, was identified. In our laboratory, C-3 epimerized metabolites of major natural vitamin D3 metabolites, 1α,25(OH)2D3, 25(OH)D3 and 24,25-dihydroxyvitamin D3 [24,25(OH)2D3], and a synthetic analog, 22-oxacalcitriol [22-oxa-1α,25(OH)2D3, OCT], were identified. In addition, other novel metabolites of OCT were assigned to two kinds of C-25 dehydrates, 25-dehydroxy-25-ene-22-oxa-1α-hydroxyvitamin D3 [25-ene-22-oxa-1α(OH)D3] and 25-dehydroxy-24-ene-22-oxa-1α-hydroxyvitamin D3 [24-ene-22-oxa-1α(OH)D3]. In this mini-review, the identification of C-3 epimers of vitamin D3 compounds and C-25 dehydrates of OCT using 1H-NMR and LC-MS techniques is described. Furthermore, the cell-specific generation and biological activity of these novel metabolites are reviewed.<br>
Journal
-
- Journal of Health Science
-
Journal of Health Science 49 (4), 260-266, 2003
The Pharmaceutical Society of Japan
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679473964416
-
- NII Article ID
- 110003609073
-
- NII Book ID
- AA11316464
-
- COI
- 1:CAS:528:DC%2BD3sXmt1Knurk%3D
-
- ISSN
- 13475207
- 13449702
-
- NDL BIB ID
- 6619990
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed